| |
Records |
Links |
|
Author |
Addiction Suisse |
|
| |
Title |
Bases théoriques de la prévention des dépendances; concepts de prévention des dépendances; prévention structurelle des dépendances : une approche axée sur le contexte; prévention des dépendances centrée sur la personne; evaluation de projets dans le cadre de la prévention des dépendances |
Type  |
Book Whole |
| |
Year |
2013 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
28 |
|
| |
Keywords |
prevention; indicated prevention; peer prevention; intervention (persuasion to treatment); social policy prevention approach; prevention campaign; licit drug; alcohol; prevention strategy; prevention outcome; concept; evaluation |
|
| |
Abstract |
La prévention cherche à atteindre des publics cibles différents par des méthodes variées. Les objectifs de la prévention sont multidimensionnels et dépendent de nombreux facteurs. Les documents que nous vous proposons offrent un aperçu des thématiques de la prévention des dépendances. Les personnes qui souhaiteraient approfondir le sujet y trouveront également des références. Les bases théoriques exposent les principales théories sur lesquelles se fonde la prévention des dépendances. Sont abordées les questions de facteurs de risque et de protection, de même que les théories de l’étiologie et de l’intervention. Les concepts de prévention des dépendances présentent deux approches habituellement utilisées centrées sur: – le moment de l’intervention – le groupe cible On distingue classiquement les mesures de prévention structurelle, qui visent à modifier les structures et l’environnement des groupes cibles, des mesures de prévention des dépendances centrée sur la personne qui agissent directement sur les individus. L’évaluation de projets dans le cadre de la prévention est complexe mais indispensable pour mieux estimer leur efficacité. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Addiction Suisse |
Place of Publication |
Lausanne |
Editor |
|
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Auch auf Deutsch vorhanden: 50-13023 |
Approved |
no |
|
| |
Call Number |
50-13024 |
Serial |
49925 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Groupement romand d'études des addictions |
|
| |
Title |
Article 3C de la Lstup |
Type |
Book Whole |
| |
Year |
2013 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
4 |
|
| |
Keywords |
government and politics; laws and regulations; drug laws; amendment; addiction care; social institution; adolescent; child; drug decriminalization; psychoactive substances; AOD consumption; AOD use, abuse, and dependence; Switzerland |
|
| |
Abstract |
L’article 3c LStup est entré en vigueur le 1er juillet 2011 avec l’ensemble des nouvelles dispositions découlant de la révision partielle de la Loi fédérale, approuvée fin 2008 en votation populaire. Cet article donne une base légale en matière d’annonce notamment s’il s’agit d’enfants ou de jeunes présentant une consommation problématique de drogues risquant de déboucher sur une addiction. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Groupement romand d'études des addictions (GREA) |
Place of Publication |
Yverdon-les-Bains |
Editor |
|
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13084 |
Serial |
49926 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
santé, Direction générale de la; Mission interministerielle de lutte contre la drogue et la toxicomanie |
|
| |
Title |
Guide des traitements de substitution aux opiacés en milieu carcéral |
Type |
Book Whole |
| |
Year |
2012 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
52 |
|
| |
Keywords |
AOD use, abuse, and dependence; AOD dependent; treatment and maintenance; opioids in any form; drug substitution therapy; buprenorphine; methadone maintenance; prison; urinalysis; recommendations or guidelines; statistical data; France; questionnaire |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Direction générale de la santé (DGS); Mission interministerielle de lutte contre la drogue et la toxicomanie (MILDT) |
Place of Publication |
Paris; Lyon |
Editor |
|
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13094 |
Serial |
49927 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
AIDS Action Committee |
|
| |
Title |
Myths and facts about syringe availability : Massachusetts campaign for responsible syringe policy |
Type |
Book Whole |
| |
Year |
2004 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
1 |
|
| |
Keywords |
harm reduction; intravenous drug user; needle distribution and exchange; HIV infection; government and politics; public policy; United States; Massachusetts |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
AIDS Action Committee |
Place of Publication |
Boston |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13159 |
Serial |
49928 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
ANCAHRD Hepatitis C Committee and Clinical Trial and Research Committee (ed) |
|
| |
Title |
A model of care for the management of hepatitis C infection in adults |
Type |
Book Whole |
| |
Year |
2003 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
68 |
|
| |
Keywords |
government and politics; infection; viral hepatitis; hepatitis C; treatment and maintenance; adult; Australia |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCAHRD) |
Place of Publication |
Canberra |
Editor |
ANCAHRD Hepatitis C Committee and Clinical Trial and Research Committee |
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13175 |
Serial |
49929 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Archido (ed) |
|
| |
Title |
Archido-Bibliographie : Gesundheitsräume |
Type |
Book Whole |
| |
Year |
1999 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
14 |
|
| |
Keywords |
harm reduction; injection room; bibliography; international area; Germany; Austria; Switzerland |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Universität Bremen, Archido |
Place of Publication |
Bremen |
Editor |
Archido |
|
| |
Language |
German |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13179 |
Serial |
49930 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Ärztekammer Westfalen-Lippe |
|
| |
Title |
Ambulante Substitutionstherapie Opiatabhängiger (ASTO) : Qualitätssicherung in der ambulanten Substitutionstherapie Opiatabhängiger |
Type |
Book Whole |
| |
Year |
2003 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
2 |
|
| |
Keywords |
treatment and maintenance; AOD dependent; opioids in any form; outpatient care; social services; drug substitution therapy; quality control; Germany; North Rhine-Westphalia |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Ärztekammer Westfalen-Lippe |
Place of Publication |
Münster |
Editor |
|
|
| |
Language |
German |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13182 |
Serial |
49931 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Association Safe |
|
| |
Title |
Qu'est-ce que la réduction des risques? (RDR) |
Type |
Book Whole |
| |
Year |
2004 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
2 |
|
| |
Keywords |
harm reduction; needle distribution and exchange; addiction care; drug user; illicit drug; France |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Association Safe |
Place of Publication |
Paris |
Editor |
|
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
1 Physisch vorhanden |
Approved |
no |
|
| |
Call Number |
50-13192 |
Serial |
49932 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Australian National Council on AIDS, Hepatitis C. and Related Diseases (ed) |
|
| |
Title |
National hepatitis C testing policy |
Type |
Book Whole |
| |
Year |
2003 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
xiii, 68 |
|
| |
Keywords |
government and politics; viral hepatitis; hepatitis C; diagnosis; strategy; international area; Australia |
|
| |
Abstract |
Hepatitis C is the most commonly diagnosed notifiable communicable infection in Australia. The Hepatitis C Virus Projections Working Group of the Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCAHRD) released the report Estimates and Projections of the Hepatitis C Epidemic in Australia 2002 which stated that in 2001 approximately 210 000 people in Australia had hepatitis C antibodies and approximately 16 000 new infections were occurring annually. Although the virus may be cleared after infection, it persists in 65–85 per cent of those infected. Of these cases, 5–10 per cent develop cirrhosis after 20 years and 3–5 per cent develop hepatocellular carcinoma. Thus, hepatitis C represents a significant public health concern. A diagnosis of hepatitis C also has multiple implications in relation to an individual’s work, family and quality of life. Caring for a person diagnosed with hepatitis C calls for informed and sensitive management. Health professionals, infected people and the community recognise that clear and rigorous guidelines for diagnosing and monitoring hepatitis C infection are needed and that the guidelines should take account of the life of the infected individual as well as of the populations at risk and their needs. The National Hepatitis C Testing Policy has been formulated under the auspices of the Australian National Council on AIDS, Hepatitis C and Related Diseases (the Commonwealth’s principal independent advisory body on hepatitis C) and the Intergovernmental Committee on AIDS, Hepatitis C and Related Diseases (the intergovernmental committee responsible for implementation of the National Hepatitis C Strategy). The policy is intended to provide advice to government, health professionals, industry, hepatitis C–infected individuals, and the community in general, about matters associated with testing. Anti-HCV antibody testing first became available in 1990. The number of hepatitis C antibody tests carried out each year in Australia is approaching 2 million (including blood service and diagnostic testing) and about 50 000 for supplemental immunoassay tests. New technologies have offered further dimensions in testing strategies. Qualitative and quantitative nucleic acid tests (NAT) are useful in detecting infection in the early stages and in assessing clearance of the virus and the effect of treatment. Qualitative NAT can be used to determine if infants of infected mothers have been infected. Genotype testing is useful in predicting the response to treatment because some hepatitis C subtypes are more sensitive to therapy than others. In addition to these tests, short incubation immuno-assays are available and home kits are being developed for marketing. The National Hepatitis C Testing Policy offers clarification on the use of hepatitis C tests and the interpretation of diagnostic tests in the context of other laboratory tests and specific clinical situations. There are 32 recommendations. Recommendations 1 to 19 outline the principles for hepatitis C testing and emphasise the need for individuals to be informed about testing and to be tested voluntarily. Testing must be of benefit to the individual, and confidentiality must be maintained at all levels of testing. People with hepatitis C should have access to treatment and ongoing monitoring. Particular attention should be paid to groups such as Aboriginal and Torres Strait Islander peoples and people from culturally and linguistically diverse backgrounds, who may have difficulty gaining access to health services; populations at risk, such as injecting drug users and people in custodial settings, also warrant particular attention. Recommendations 20 to 29 outline diagnostic strategies. Appropriate testing standards are to be applied by all laboratories undertaking testing for hepatitis C. Minimum practices, which should be adopted by all laboratories, include the need to confirm antibody reactivity by two separate immuno-assays based on different antigens and different immuno-assay formats. Discordant test results in two immunoassays may require additional testing by qualitative NAT or referral to a reference laboratory, or both. The National Serology Reference Laboratory should keep laboratories up to date on appropriate combinations of immuno-assays, to avoid common cross-reactivity between tests. The utility of qualitative NAT in testing newly diagnosed hepatitis C sero-positive individuals and in testing infants born to hepatitis C sero-positive mothers is discussed in Chapter 6. The use of short incubation tests is not supported—except in the case of screening potential organ donors, when the tests should be performed by suitably trained laboratory personnel. Home sampling or testing is not supported for the Australian situation. The regulation of hepatitis C test kits and the supporting Quality Assurance Program are dealt with in Recommendations 30 to 32. An outline for a classification system for hepatitis C tests and test kits is presented; the system offers a choice of test protocols within a given situation and a framework for evaluation of test kits and for incorporating new technology as it emerges. The policy recommends that it be a condition of registration of hepatitis C kits by the Therapeutic Goods Administration that laboratories using the kits participate in the National Serology Reference Laboratory’s hepatitis C Quality Assurance Program. Standard and reference testing for hepatitis C should be provided by public and private sector laboratories that comply with the National Association of Testing Authorities – Royal College of Pathologists of Australasia audit and accreditation mechanisms, according to National Pathology Accreditation Advisory Committee guidelines. The National Hepatitis C Testing Policy will clarify for all concerned the testing parameters for hepatitis C and guide the approach to diagnosis and management. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCAHRD) |
Place of Publication |
Canberra |
Editor |
Australian National Council on AIDS, Hepatitis C. and Related Diseases |
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13198 |
Serial |
49933 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Blue Earth County staff |
|
| |
Title |
Key points to the harm reduction model |
Type |
Book Whole |
| |
Year |
1990 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
1 |
|
| |
Keywords |
harm reduction; program implementation; employee-related issues; United States |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Association of Minnesota Counties (AMC) |
Place of Publication |
Mankato |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13229 |
Serial |
49934 |
|
| Permanent link to this record |
